Understanding GLP-1 Drugs These pharmaceuticals replicate a bodily gut hormone known as GLP-1 (glucagon-like peptide-1) and are mainly employed for managing type 2 diabetes and body weight
Rendered confocal z-stacks were generated using Volocity v.6.3 (Perkin Elmer) and Imaris v.4.3 (Bitplane)
Mahajan S, Feng F, Hu S, Lu Y, Gupta A, Murugiah K, Gao Y, Lu J, Liu J, Zheng X, Spatz ES, Zhang H, Krumholz HM , Li J
Clinical trials involving Mounjaro have shown that people can lose an average 22.5% of their starting body weight by reaching the maximum maintenance dose of 15mg per week after 72 weeks
CLICK HERE TO GET THE FOX NEWS APP "Tirzepatide (Mounjaro, Zepbound) is a dual GIP/GLP-1 agonist and has shown even greater weight loss in trials with a similar side effect profile," Fitch said